Drug
Depakote ER
Depakote ER is a pharmaceutical drug with 6 clinical trials. Historical success rate of 80.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
80.0%
Based on 4 completed trials
Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
1(17%)
Phase Distribution
Ph phase_2
2
33%
Ph phase_3
1
17%
Ph phase_4
2
33%
Ph not_applicable
1
17%
Phase Distribution
0
Early Stage
2
Mid Stage
3
Late Stage
Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
1(16.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
4 of 6 finished
Non-Completion Rate
33.3%
2 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(4)
Terminated(2)
Detailed Status
Completed4
Withdrawn1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
80.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (33.3%)
Phase 31 (16.7%)
Phase 42 (33.3%)
N/A1 (16.7%)
Trials by Status
withdrawn117%
completed467%
terminated117%
Recent Activity
0 active trials
Showing 5 of 6
terminatedphase_3
Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia
NCT00315900
completedphase_4
Depakote ER in Bipolar Depression
NCT00186186
withdrawnphase_2
Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence
NCT00204503
completedphase_2
Pediatric Switch Study for Children and Adolescent Patients With Epilepsy
NCT00646711
completedphase_4
A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote DR
NCT00334347
Clinical Trials (6)
Showing 6 of 6 trials
NCT00315900Phase 3
Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia
NCT00186186Phase 4
Depakote ER in Bipolar Depression
NCT00204503Phase 2
Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence
NCT00646711Phase 2
Pediatric Switch Study for Children and Adolescent Patients With Epilepsy
NCT00334347Phase 4
A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote DR
NCT00222482Not Applicable
Depakote ER in Borderline Personality Disorder
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6